Journal of Current Glaucoma Practice

Register      Login

VOLUME 11 , ISSUE 2 ( May-August, 2017 ) > List of Articles

REVIEW ARTICLE

Steroid-induced Glaucoma: An Avoidable Irreversible Blindness

SS Pandav, Savleen Kaur, Sushmita Kaushik, Sonia Phulke

Citation Information : Pandav S, Kaur S, Kaushik S, Phulke S. Steroid-induced Glaucoma: An Avoidable Irreversible Blindness. J Curr Glaucoma Pract 2017; 11 (2):67-72.

DOI: 10.5005/jp-journals-10028-1226

License: CC BY 3.0

Published Online: 00-08-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Phulke S, Kaushik S, Kaur S, Pandav SS. Steroid-induced Glaucoma: An Avoidable Irreversible Blindness. J Curr Glaucoma Pract 2017;11(2):67-72.


PDF Share
  1. Use of ACTH and cortisone. Trans Am Ophthalmol Soc 1950;48:293-296.
  2. Tissue culture of ocular fibroblast. Ann Ophthalmol 1975 Dec;7(12):1551-1554.
  3. The importance of the mucopolysaccharides in intraocular pressure regulation. Invest Ophthalmol Vis Sci 1975 Mar;14(3):173-176.
  4. Mucopolysaccharides and pathogenesis of cortisone glaucoma. Klin Monatsbl Augenheilkd 1974 Jul;165(1):5-10.
  5. The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Invest Ophthalmol Vis Sci 1990 Dec;31(12):2568-2571.
  6. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1992 Jun;33(7):2242-2250.
  7. Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-induced glaucoma. Exp Eye Res 1973 Oct;17(1):19-31.
  8. Electronic microscopic studies of the trabecular meshwork in corticosteroid glaucoma. Klin Monastbl Augenheilkd 1979 Mar;174(3):421-428.
  9. The drainage of aqueous humour (editorial). Invest Ophthalmol Vis Sci 1975 Jan;14(1):1-3.
  10. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res 1999 Sep;18(5):629-667.
  11. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1037-1047.
  12. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2004 Aug;138(2); 286-287.
  13. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2001 Dec;42(13):3173-3181.
  14. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci 2001 Jan;42(1):145-152.
  15. Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone. Invest Ophthalmol Vis Sci 2008 May;49(5):1886-1897.
  16. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci 2003 Feb;44(2):473-485.
  17. cDNA microarray analysis of gene expression changes induced by dexamethasone in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2002 Dec;43(12):3691-3697.
  18. Intraocular pressure elevation in a child due to the use of inhalation steroids—a case report. Bull Soc Belge Ophtalmol 2001;(280):97-100.
  19. Marked intraocular pressure response to instillation of corticosteroids in children. Am J Ophthalmol 1991 Oct 15;112(4):450-454.
  20. Outcome of ocular steroid hypertensive response in children. J Glaucoma 2016 Apr;25(4):343-347.
  21. Steroid-induced glaucoma and childhood blindness. Br J Ophthalmo 2015 Nov;99(11):1454-1461.
  22. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol Vis Sci 1965 Apr;4:198-205.
  23. Statistical attributes of the steroid hypertensive response in the clinically normal eye.I. The demonstration of three levels of response. Invest Ophthalmol Vis Sci 1965 Apr;4:187-197.
  24. The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 1966 Jan;75(1):32-35.
  25. Inheritance of dexamethasone hypertension and glaucoma. Arch Ophthalmol 1967 Jun;77(6):747-751.
  26. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 1963 Oct;70:492-499.
  27. Topical corticosteroids testing in glaucoma siblings. Arch Ophthalmol 1966 Oct;76(4):484-487.
  28. Topical corticosteroids and heredity in primary open angle glaucoma. Am J. Ophthalmol 1964 Apr;57:543-551.
  29. High myopia and primary open-angle glaucoma. Am J Ophthalmol 1966 Dec;62(6):1038-1043.
  30. Permanent glaucomatous visual loss after photorefractive keratectomy. J Cataract Refract Surg 1998 May;24(5):715-718.
  31. Progression of end-stage glaucoma after laser in situ keratomileusis. J Cataract Refract Surg 2002;28(2):356-359.
  32. Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology 2009 Sep;116(9):1818-1830.
  33. Interface fluid after LASIK: misleading tonometry can lead to end-stage glaucoma. J Cataract Refract Surg 2000 Apr;26(4):471-472.
  34. Steroid-induced glaucoma after laser in situ keratomileusis associated with interface fluid. Ophthalmology 2002 Apr;109(4):659-665.
  35. Diabetes mellitus and primary open-angle glaucoma. Am J Ophthalmol 1971;1(1 pt 1):1-16.
  36. Steroid responsiveness in connective tissue diseases. Br J Ophthalmol 1983 Jul;67(7):487-490.
  37. Krukenberg's spindles and primary open angle glaucoma. Arch Ophthalmol 1966 Nov;76(5):635-639.
  38. Traumatic hyphema, angle recession, dexamethasone hypertension and glaucoma. Arch Ophthalmol 1967 Dec;78(6):714-721.
  39. Glaucoma secondary to benign adrenal adenoma. Am J Ophthalmol 1974 Sep;78(3):497-500.
  40. Glaucoma from topically applied steroids. Arch Dermatol 1976 Sep;112(9):1326.
  41. Glaucoma following the application of corticosteroid to the skin of the eyelids.Br J Dermatol 1976 Aug;95(2):207-208.
  42. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am J Ophthalmol 1972 Sep;74(3):501-504.
  43. Periocular injection of steroids. Trans Am Acad Ophthalmol Otolaryngol 1972 May-Jun;76(3):695-705.
  44. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol 1976 Jul;82(1):90-93.
  45. Dexamethasone intravitreal implant in patients with macular oedema related to branch or central retinal vein occlusion twelve- month study results. Ophthalmology 2011 Dec;118(12):2453-2460.
  46. Intraocular pressure rise after intravitreal triamcinolone. Am J Ophthalmol 2005 Mar;139(3):575.
  47. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection. Invest Ophthalmol Vis Sci 2009 Feb;50(2):573-576.
  48. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004 Nov;138(5):740-743.
  49. Systemic steroids and ocular fluid dynamics. I. Analysis of the sample as a whole: Influence of dosage and duration of therapy. Acta Ophthalmol (Copenh) 1972;50(5):665-63.
  50. Systemic steroids and ocular fluid dynamics. II. Systemic versus topical steroids. Acta Ophthalmol (Copenh) 1972;50(5):664-676.
  51. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology 1995 Feb;102(2):177-179.
  52. Steroid-Induced Glaucoma. In: Shields Textbook of Glaucoma. 6th edition. Philadelphia, PA, USA: Lippincott Williams and Wilkins; 2011. pp. 344-349.
  53. Increased intraocular pressure induced by corticosteroid. Am J Ophthalmol 1976 Sep;82(3):492-495.
  54. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol 2012;6:1253-1258.
  55. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 2000 Jun;107(6):1157–1163.
  56. Cortisone-induced glaucoma: a report on 44 affected eye. J Fr Ophthalmol 1981;4(6-7):503-508.
  57. Effect of fluorometholone (FML) on the intraocular pressure of corticosteroid responders. Br J Ophthalmol 1984 Aug;68(8):581-584.
  58. Comparative anti-inflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential. Arch Ophthalmol 1992 Jan;110(1):118-120.
  59. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am J Ophthalmol 1972;74(3):501-504.
  60. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 2006 Apr;17(2):163-167.
  61. Experimental and clinical investigation of a non-hormonal anti-inflammatory eye ointment. Ophthalmic Res 1973;5(5):253-289.
  62. Flurbiprofen and intraocular pressure. Ann Ophthalmol 1981 Jul;13(7):831-833.
  63. The effect of diclofenac sodium ophthalmic solution on intraocular pressure following cataract extraction. Ophthalmic Surg 1992 Mar;23(3):170-175.
  64. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection. Invest Ophthalmol Vis Sci 2009 Feb;50(2):573-576.
  65. Prevalence and management of elevated intraocular pressure after placement of an Intravitreal sustained-release steroid implant. Curr Opin Ophthalmol 2009 Mar;20(2):99-103.
  66. Anecortave acetate as monotherapy for the treatment of subfoveal neovascularization in age-related macular degenerations: twelve-month clinical outcomes. Ophthalmology 2003 Dec;110(12):2372-2383.
  67. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma. Arch Ophthalmol 2009 Feb;127(2):173-178.
  68. External trabeculotomy for the treatment of steroid-induced glaucoma. J Glaucoma 2000 Dec;9(6):483-485.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.